Rohatiner, A Z <br/><br/>
High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemia.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Aug 2000 
 - 1007-15 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1023/a:1008333903220  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Age Factors<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bone Marrow Transplantation<br/>Cytarabine--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Female<br/>Humans<br/>Leukemia, Myeloid, Acute--therapy<br/>Male<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Prognosis<br/>Survival Analysis<br/>Thioguanine--administration & dosage<br/>Transplantation, Autologous<br/>Treatment Outcome<br/>Whole-Body Irradiation